PALM BEACH GARDENS, Fla., Feb. 16, 2011 /PRNewswire/ -- Children's AccuDial® has been named as an award finalist by the internationally known Edison Best New Product Awards™. Children's AccuDial, a product line of AccuDial Pharmaceutical, Inc., is a finalist in the Consumer Packaged Goods category, one of 12 categories honored by the Edison Awards.
The distinguished awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring America's drive to remain in the forefront of innovation, creativity, and ingenuity in the global economy.
"This year's awards recognize a broad array of innovations, including far-reaching products, services, and technologies that impact daily life," said Edison Awards Steering Committee chair, Sarah Miller Caldicott, a great-grandniece of Thomas Edison. "The awards applaud the forward-thinking innovations for which Thomas Edison remains internationally admired. It's exciting to see companies like AccuDial continuing his legacy of challenging conventional thinking."
"It is humbling to be nominated and recognized with some of the most innovative products, brands, and business leaders in America," said AccuDial Pharmaceutical, Inc.'s CEO, Robert Terwilliger. "What an honor for our revolutionary product line to be acknowledged at this esteemed showcase event."
The ballot of nominees for the Edison Best New Product Awards is judged by roughly 2,000 members of the not-for-profit Marketing Executives Networking Group (MENG), an organization comprising America's top marketing professionals and academics. In a comprehensive peer-review process, the nominees are judged on Marketplace Innovation, Marketplace Success, Technological Innovation, Market Structure Innovation, Societal Impact, and Design Innovation.
Winners of the gold, silver, and bronze awards will be announced April 5, 2011, at the historic Capitale ballroom in New York. In addition to announcing this year's Best New Product Award recipients, the evening will feature the presentation of the prestigious Edison Achievement Award to Alan Mulally, CEO of Ford Motor Company, and to John Hendricks, founder and chairman of Discovery Communications, both of whom have made a significant and lasting contribution to innovation throughout their careers.
The Edison Awards Steering Committee is comprised of senior executives, with diverse marketing, scientific, and business backgrounds, who monitor the development and successful launch of innovative products each year. The committee is responsible for bestowing the annual Edison Achievement Awards and serves as a guidepost in developing the list of nominees who are presented to the Edison Best New Product Award judges.
The 2011 Edison Awards are sponsored by The Nielsen Company, Discovery Channel, Science Channel, Spencer Trask, and BzzAgent. The Edison Awards are granted under the aegis of the Thomas A. Edison Papers at Rutgers University, a globally recognized research network dedicated to the study of innovation and its application in the 21st century. For more information about the Edison Award finalists, please visit www.edisonawards.com.
About AccuDial Pharmaceutical, Inc.
AccuDial Pharmaceutical, Inc. is positioned to change the way liquid medications will be dosed globally. It is the only brand with a patented rotating weight-based dosing system designed to administer over-the-counter medications safely and effectively. For more information about AccuDial, visit accuratedose.com or call 561.429.6886.
For more information about this press release, contact Enid Atwater at email@example.com or 561.844.1778, ext. 21.
The information contained in this press release include "forward-looking statements." All statements other than statements of historical facts included in this press release, including the company's prospects, plans, financial position, and business strategy, may constitute forward-looking statements. These statements are based on the beliefs and assumptions of our management and on the information currently available to our management at the time of such statements. Forward-looking statements generally can be identified by the words "believes," "expects," "anticipates," "intends," "plans," "estimates," or similar expressions that indicate future events and trends. Although the company believes that the expectations reflected in these forward-looking statements are reasonable, the company can give no assurance that these expectations will prove to be correct, and the company's actual results may differ significantly from the results discussed in these forward-looking statements. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events, or otherwise.
SOURCE AccuDial Pharmaceutical, Inc.